Please login to the form below

Not currently logged in
Email:
Password:

Editas Medicine adds to board of directors

Alnylam Pharmaceuticals’ Dr Akshay Vaishnaw joins

Editas Medicine Dr Akshay VaishnawCambridge, Massachusetts-based Editas Medicine has appointed Dr Akshay Vaishnaw to its board of directors.

Dr Vaishnaw brings over 30 years of pharmaceuticals experience to the genome editing company, and currently serves as both executive vice president of research and development and chief medical officer at Alnylam Pharmaceuticals.

Prior to joining Alnylam in 2006, he worked in medical research at Biogen and held roles of increasing responsibility before becoming senior director of medical research.

Katrine Bosley, Editas Medicine's president and chief executive officer, said: “I am delighted to welcome Akshay to our board of directors.

“He has extensive clinical development experience, a passion for scientific excellence, and achieved significant accomplishments as part of the leadership team that has built Alnylam.

“We believe Akshay's perspective and advice will be invaluable as we continue to advance the organisation and drive innovative new medicines to treat genetic diseases.”

2nd August 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...

Infographics